Katharina Domschke Selected Research

Anxiety Disorders (Anxiety Disorder)

12/2021	The cognitive anxiety sensitivity treatment (CAST) in anxiety prevention - Focus on separation anxiety and interoception.
1/2021	Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis.
1/2021	Exploratory drive, fear, and anxiety are dissociable and independent components in foraging mice.
11/2020	An investigation of genetic variability of DNA methyltransferases DNMT3A and 3B does not provide evidence for a major role in the pathogenesis of panic disorder and dimensional anxiety phenotypes.
10/2019	The role of adenosine receptors in mood and anxiety disorders.
1/2019	Human BDNF rs6265 polymorphism as a mediator for the generalization of contextual anxiety.
1/2019	Anxiety in Late Life: An Update on Pathomechanisms.
1/2019	A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disorders.
1/2018	Oxytocin and Anxiety Disorders.
1/2017	Neuropeptide S Receptor Gene Variation Differentially Modulates Fronto-Limbic Effective Connectivity in Childhood and Adolescence.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katharina Domschke Research Topics

Disease

33	Anxiety Disorders (Anxiety Disorder) 12/2021 - 06/2008
32	Panic Disorder (Panic Attack) 12/2021 - 06/2004
21	Mental Disorders (Mental Disorder) 04/2022 - 01/2010
15	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2019 - 01/2012
14	Mood Disorders (Mood Disorder) 03/2022 - 03/2008
13	Schizophrenia (Dementia Praecox) 04/2022 - 01/2010
12	Major Depressive Disorder (Major Depressive Disorders) 04/2022 - 05/2011
9	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 10/2022 - 01/2016
9	Psychotic Disorders (Schizoaffective Disorder) 02/2022 - 07/2013
7	Depressive Disorder (Melancholia) 11/2021 - 01/2019
5	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 08/2011
5	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 01/2019
4	Social Phobia 01/2018 - 06/2009
3	Separation Anxiety (Separation Anxiety Disorder) 12/2021 - 01/2018
3	Autoimmune Diseases of the Nervous System 10/2020 - 01/2020
3	Dementia (Dementias) 09/2020 - 01/2010
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 08/2020 - 04/2005
3	Seizures (Absence Seizure) 06/2020 - 01/2018
3	Sleep Deprivation 10/2019 - 01/2018
3	Genetic Predisposition to Disease (Genetic Predisposition) 06/2019 - 07/2012
3	Wounds and Injuries (Trauma) 03/2019 - 01/2012
2	Fatigue 08/2022 - 01/2020
2	Infections 01/2022 - 06/2020
2	Autism Spectrum Disorder 01/2022 - 01/2020
2	Genetic Risk Score 01/2022 - 01/2017
2	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2021 - 07/2020
2	Neoplasms (Cancer) 09/2020 - 10/2019
2	Brain Diseases (Brain Disorder) 07/2020 - 06/2020
2	Movement Disorders (Movement Disorder) 06/2020 - 01/2019
2	Hyponatremia 06/2020 - 01/2009
2	Catatonia 01/2020 - 01/2019
2	Hypersensitivity (Allergy) 01/2020 - 01/2017
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2020 - 01/2019
2	Ischemia 10/2019 - 01/2019
2	War-Related Injuries 06/2019 - 06/2016
2	Agoraphobia 01/2019 - 01/2018
2	Phobic Disorders (Phobia) 01/2018 - 05/2015
1	Encephalomyelitis (Myeloencephalitis) 02/2022
1	Confusion (Bewilderment) 02/2022
1	Leukocytosis (Pleocytosis) 01/2022
1	Autistic Disorder (Autism) 01/2022
1	Huntington Disease (Huntington's Disease) 01/2022

Drug/Important Bio-Agent (IBA)

16	NeuropeptidesIBA 11/2020 - 08/2011
13	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
10	AutoantibodiesIBA 10/2022 - 01/2020
10	Antidepressive Agents (Antidepressants)IBA 08/2022 - 01/2009
10	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 10/2012
9	AntibodiesIBA 04/2022 - 01/2020
9	Monoamine Oxidase (MAO)IBA 01/2020 - 04/2005
8	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2010
7	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2020 - 02/2010
7	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 05/2012 - 06/2005
6	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2021 - 06/2009
6	sodium bisulfite FDA Link 11/2020 - 08/2014
5	gamma-Aminobutyric Acid (GABA)IBA 01/2022 - 01/2012
5	Glutamic Acid (Glutamate)FDA Link 01/2022 - 01/2012
5	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 11/2021 - 01/2009
5	Biological ProductsIBA 01/2020 - 01/2012
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2022 - 01/2019
4	N-Methylaspartate (NMDA)IBA 01/2022 - 01/2019
4	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 01/2012
4	Anti-Anxiety Agents (Anxiolytics)IBA 01/2021 - 01/2012
4	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2021 - 01/2018
4	CytokinesIBA 01/2021 - 07/2012
4	Dopamine (Intropin)FDA LinkGeneric 10/2019 - 06/2005
3	AlbuminsIBA 06/2021 - 06/2020
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
3	EnzymesIBA 11/2020 - 01/2012
3	TransferasesIBA 06/2019 - 06/2004
3	glutamate decarboxylase 1IBA 06/2019 - 01/2012
3	Neuropeptide YIBA 06/2019 - 06/2008
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2017 - 01/2009
2	ElementsIBA 12/2021 - 01/2018
2	Interleukin-8 (Interleukin 8)IBA 01/2021 - 10/2020
2	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021 - 01/2012
2	Immunoglobulin G (IgG)IBA 12/2020 - 06/2020
2	Oligoclonal BandsIBA 12/2020 - 06/2020
2	MicroRNAs (MicroRNA)IBA 11/2020 - 01/2015
2	Nerve Growth Factors (Neurotrophins)IBA 11/2020 - 01/2017
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 01/2019
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 10/2019 - 01/2010
2	Tryptophan HydroxylaseIBA 06/2019 - 08/2011
2	catechol (pyrocatechol)IBA 06/2019 - 06/2004
2	OrexinsIBA 01/2019 - 11/2014
2	Oxidoreductases (Dehydrogenase)IBA 11/2018 - 01/2012
2	Oxytocin (Pitocin)FDA LinkGeneric 01/2018 - 01/2017
2	Peptides (Polypeptides)IBA 03/2016 - 01/2016
2	Adenosine (Adenocard)FDA LinkGeneric 01/2016 - 11/2014
2	Caffeine (No Doz)FDA LinkGeneric 11/2014 - 01/2010
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2013 - 10/2012
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2013 - 10/2010
1	Serum AlbuminIBA 04/2022
1	D-Aspartic Acid (D Aspartate)IBA 03/2022
1	N 30IBA 01/2022
1	vanoxerine (I 893)IBA 01/2022

Therapy/Procedure

7	Therapeutics 01/2021 - 11/2010
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
2	Aftercare (After-Treatment) 01/2018 - 01/2009
1	Deep Brain Stimulation 05/2022
1	Length of Stay 01/2022